Header cover image

Egyptian (CASE/EGX) Pharma Industry Analysis

UpdatedDec 10, 2024
DataAggregated Company Financials
Companies11
  • 7D-0.08%
  • 3M21.3%
  • 1Y25.6%
  • YTDn/a

The Pharma is pretty flat in the last 7 days, but Alexandria For Pharmaceuticals & Chemical Industries has stood out, gaining 7.7%. As for the the longer term, the industry is up 24% over the past 12 months. Looking forward, earnings are forecast to grow by 31% annually.

Industry Valuation and Performance

Has the Egyptian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 10 Dec 2024ج.م23.7bج.م23.7bج.م2.4b7.3x10x1x
Thu, 07 Nov 2024ج.م24.5bج.م22.0bج.م2.2b7.1x11.4x1.1x
Sat, 05 Oct 2024ج.م22.6bج.م22.1bج.م2.1b6.8x10.5x1x
Mon, 02 Sep 2024ج.م19.4bج.م22.1bج.م2.4b5.6x8x0.9x
Wed, 31 Jul 2024ج.م18.7bج.م21.3bج.م2.5b5x7.6x0.9x
Fri, 28 Jun 2024ج.م19.2bج.م20.8bج.م2.3b7x8.4x0.9x
Sun, 26 May 2024ج.م18.7bج.م20.1bج.م1.8b7.8x10.2x0.9x
Tue, 23 Apr 2024ج.م21.0bج.م19.3bج.م1.7b8.4x12.1x1.1x
Thu, 21 Mar 2024ج.م21.8bج.م19.2bج.م2.3b8.8x9.5x1.1x
Sat, 17 Feb 2024ج.م23.2bج.م18.5bج.م2.4b9.7x9.7x1.3x
Mon, 15 Jan 2024ج.م18.9bج.م16.4bج.م2.2b6.9x8.6x1.2x
Wed, 13 Dec 2023ج.م18.6bج.م16.5bج.م2.2b8.6x8.6x1.1x
Fri, 10 Nov 2023ج.م15.3bج.م15.4bج.م1.9b6.9x7.9x1x
Sun, 08 Oct 2023ج.م13.8bج.م15.3bج.م1.9b5.5x7.2x0.9x
Tue, 05 Sep 2023ج.م14.3bج.م15.9bج.م2.0b7.2x7.1x0.9x
Thu, 03 Aug 2023ج.م13.3bج.م15.6bج.م2.1b6.8x6.3x0.9x
Sat, 01 Jul 2023ج.م13.9bج.م16.2bج.م2.2b5.4x6.3x0.9x
Mon, 29 May 2023ج.م13.8bج.م16.2bج.م2.4b4.5x5.7x0.9x
Wed, 26 Apr 2023ج.م14.5bج.م16.2bج.م2.3b5.2x6.2x0.9x
Fri, 24 Mar 2023ج.م13.9bج.م15.7bج.م2.3b5.2x6.1x0.9x
Sun, 19 Feb 2023ج.م15.0bج.م15.7bج.م2.3b5.3x6.5x1x
Tue, 17 Jan 2023ج.م15.1bج.م15.6bج.م2.3b5.4x6.6x1x
Thu, 15 Dec 2022ج.م15.1bج.م15.6bج.م2.3b5.3x6.6x1x
Sat, 12 Nov 2022ج.م13.0bج.م15.1bج.م2.2b5.1x6x0.9x
Mon, 10 Oct 2022ج.م12.6bج.م15.1bج.م2.2b4.7x5.8x0.8x
Wed, 07 Sep 2022ج.م12.9bج.م14.3bج.م2.0b6.1x6.3x0.9x
Fri, 05 Aug 2022ج.م12.6bج.م14.1bج.م1.9b5.7x6.5x0.9x
Sun, 03 Jul 2022ج.م11.9bج.م14.1bج.م1.9b5.8x6.2x0.8x
Tue, 31 May 2022ج.م11.8bج.م11.9bج.م1.7b5.6x7.1x1x
Thu, 28 Apr 2022ج.م12.3bج.م11.9bج.م1.7b5.7x7.4x1x
Sat, 26 Mar 2022ج.م12.9bج.م13.7bج.م1.8b6.6x7x0.9x
Mon, 21 Feb 2022ج.م13.1bج.م13.3bج.م1.8b6.5x7.2x1x
Wed, 19 Jan 2022ج.م13.5bج.م13.3bج.م1.8b6.3x7.4x1x
Fri, 17 Dec 2021ج.م12.8bج.م13.3bج.م1.8b5.9x7.1x1x
Price to Earnings Ratio

7.1x


Total Market Cap: ج.م12.8bTotal Earnings: ج.م1.8bTotal Revenue: ج.م13.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Egyptian Pharma Industry Price to Earnings3Y Average 7.6x202220232024
Current Industry PE
  • Investors are optimistic on the Egyptian Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 10.0x which is higher than its 3-year average PE of 7.6x.
  • The industry is trading close to its 3-year average PS ratio of 0.96x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 9.4% per year over the last three years.
  • Revenues for these companies have grown 21% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Egyptian Pharma compare with similar industries?

EG Market1.94%
Healthcare0.66%
Pharma-0.082%
Pharma-0.082%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AXPH Alexandria For Pharmaceuticals & Chemical Industriesج.م317.854.8%
+ج.م72.7m
78.5%PE7.3x
MIPH MINAPHARM Pharmaceuticalsج.م192.552.3%
+ج.م47.0m
-18.5%PS0.5x
NIPH EI- Nile for Pharmaceuticals and Chemical Industriesج.م54.123.5%
+ج.م18.5m
-45.5%PE22.2x
MPCI Memphis Pharmaceuticals & Chemical Industriesج.م51.790.1%
+ج.م281.3k
-21.3%PE0.9x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BIOC

ج.م39.99

GlaxoSmithKlineE

7D

-0.7%

1Y

11.9%

MIPH

ج.م192.55

MINAPHARM Pharmaceuticals

7D

2.3%

1Y

-18.5%